New Insomnia Treatment Approved

January 16, 2020

New Insomnia Treatment Approved

Orexin receptor antagonist DAYVIGO TM has been approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults. The medication was tested in 2,000 patients before being approved by the FDA. Clinical trials are much more than just a drug, patient and a placebo, which is why Yourway offers ancillary material sourcing, including medical equipment and devices as well as diagnostic and testing equipment.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?